Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowWhole-Body IrradiationBone Marrow CellsLeukemiaAnemia, AplasticTransplantation ConditioningTransplantation ChimeraTransplantation, AutologousBusulfanTissue DonorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematopoietic Stem Cell TransplantationGraft SurvivalLeukocyte TransfusionGraft vs Tumor EffectHistocompatibility TestingRecurrenceHistocompatibilityRadiation ChimeraGraft vs Host ReactionGraft vs Leukemia EffectLeukemia, Myeloid, AcuteLymphocyte DepletionPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamideRemission InductionHematologic NeoplasmsAcute DiseaseLymphocyte TransfusionTransplantation, IsogeneicBone and BonesHepatic Veno-Occlusive DiseaseImmunosuppressive AgentsLeukemia, MyeloidBone Marrow PurgingMice, Inbred C57BLCombined Modality TherapyChimeraHematopoietic Stem CellsT-LymphocytesImmunosuppressionMyelodysplastic SyndromesNuclear FamilyTreatment OutcomeTime FactorsTransplantation ImmunologyHematopoiesisLiver TransplantationGraft RejectionCyclosporineSurvival AnalysisActuarial AnalysisHLA AntigensCytomegalovirus InfectionsRetrospective StudiesHematologic DiseasesFatal OutcomeMice, Inbred BALB CLymphoma, Non-HodgkinSevere Combined ImmunodeficiencyCytarabineSurvival RateBone Marrow DiseasesKidney TransplantationDisease-Free SurvivalAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesSpleenPancytopeniaGranulocyte Colony-Stimulating FactorLeukocyte CountLeukemia, Myelomonocytic, AcuteInfectionStem Cell TransplantationAnemia, Refractory, with Excess of BlastsMethotrexateLymphomaBone Marrow ExaminationEtoposideAntilymphocyte SerumCyclosporinsNeoplasm, ResidualGanciclovirMultiple MyelomaFlow CytometryMinor Histocompatibility AntigensImmunocompromised HostIsoantigensMice, Inbred AKRPrognosisBone RemodelingMice, Inbred C3HImmunophenotypingColony-Forming Units AssayLife TablesLymphocyte ActivationCytogenetics